Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Progressive supranuclear palsy revisited

I Litvan¹

¹Neuropharmacology Unit, Defense & Veteran Head Injury Program, Henry M. Jackson Foundation, Bethesda, Maryland, USA.

Acta Neurologica Scandinavica

|September 2, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020

Same author

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020

Same author

Swallowing disturbances in the corticobasal syndrome.

Parkinsonism & related disorders·2015

Same author

Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment.

Dementia and geriatric cognitive disorders extra·2012

Same author

Mild cognitive impairment in Parkinson's disease.

Minerva medica·2011

Same author

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Neurology·2009

Same journal

Editorial.

Acta neurologica Scandinavica·2022

Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022

Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022

Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022

Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022

Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022

See all related articles

This review revisits current knowledge on progressive supranuclear palsy (PSP), covering its history, genetics, and treatments. It also highlights emerging research avenues for this rare neurological disorder.

Area of Science:

Neurology
Neuroscience
Medical Research

Background:

Progressive supranuclear palsy (PSP) is a rare, fatal neurodegenerative disease.
Understanding the multifaceted aspects of PSP is crucial for advancing patient care.

Purpose of the Study:

To comprehensively review the current understanding of progressive supranuclear palsy (PSP).
To explore historic, epidemiologic, genetic, clinical, neuropathologic, neurochemical, diagnostic, and therapeutic aspects of PSP.
To identify and describe new research directions in PSP.

Main Methods:

Literature review and synthesis of existing research on progressive supranuclear palsy.
Analysis of data across various domains including epidemiology, genetics, and clinical presentation.

Related Experiment Videos

Identification of emerging trends and future research priorities in PSP.

Main Results:

A consolidated overview of the current state of knowledge regarding PSP.
Identification of gaps in understanding and areas requiring further investigation.
Outline of promising new research avenues for PSP.

Conclusions:

A thorough understanding of PSP's diverse aspects is essential.
Continued research into the etiology, diagnosis, and treatment of PSP is critical.
Future research should focus on novel therapeutic strategies and understanding disease mechanisms.